Send us a text
Jerry McLaughlin is Chief Executive Officer and Board Member of Life Biosciences, Inc. ( https://www.lifebiosciences.com/ ), a private biotechnology company dedicated to developing novel therapies to extend healthy human lifespan, pursuing a platform approach to develop therapeutics that can prevent, treat, and/or reverse multiple aging-related conditions. Jerry has over 30 years of experience in the biopharmaceutical industry and has been involved in the discovery, clinical development, and global commercialization of more than a dozen FDA- approved drugs with multiple successful exits. Most recently, Jerry was President and CEO for Neos Therapeutics, Inc., a commercial stage pharmaceutical company. Before that, he served as president and CEO of AgeneBio, Inc., a clinical-stage private biopharma company developing therapies for neurological and psychiatric diseases. Earlier, he held the role of senior vice president & chief commercial officer at NuPathe Inc., acquired by Teva Pharmaceuticals in 2014. Jerry began his career at Merck and was extensively involved in multiple blockbuster product launches. He holds a BA in economics from Dickinson College and an MBA from the Villanova School of Business.
Support the show
Progress, Potential, and Possibilities Podcast / Show